MF
About
Mark Frohlich is the CEO at Indapta Therapeutics. Mark Frohlich attended University of California, San Francisco.
Position in the VCSift Database
- • 1,305 investors hold the Chief Executive Officer role in VCSift. Mark Frohlich is one of them.
- • 164 investors are based in Washington, United States.
Data sourced from 410,343 investor profiles. Updated July 2026.
Investment Focus
- Location
- Washington, US
Contact Information
linkedin.com/in/••••••••
Find more investors like Mark
Search Investors